Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer

[1]  M. Dowsett,et al.  Biomarkers for the clinical management of breast cancer: International perspective , 2013, International journal of cancer.

[2]  K. Pantel,et al.  Real-time liquid biopsy in cancer patients: fact or fiction? , 2013, Cancer research.

[3]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[4]  F. Mertens,et al.  Characterization of a hotspot region on chromosome 12 for amplification in ring chromosomes in atypical lipomatous tumors , 2009, Genes, chromosomes & cancer.

[5]  J. Shaw,et al.  Detection of HER2 amplification in circulating free DNA in patients with breast cancer , 2011, British Journal of Cancer.

[6]  A. Giuliano,et al.  Prediction of breast tumor progression by integrity of free circulating DNA in serum. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. Theillet,et al.  Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. , 1997, Cancer research.

[8]  A. Schneeweiss,et al.  Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis , 2014, Breast Cancer Research and Treatment.

[9]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[10]  K. Pantel,et al.  Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression , 2012, Clinical Cancer Research.

[11]  S. Verjovski-Almeida,et al.  Perspectives of Long Non-Coding RNAs in Cancer Diagnostics , 2012, Front. Gene..

[12]  M. Ychou,et al.  High Fragmentation Characterizes Tumour-Derived Circulating DNA , 2011, PloS one.

[13]  Klaus Pantel,et al.  Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.

[14]  F. Nicolantonio,et al.  Liquid biopsy: monitoring cancer-genetics in the blood , 2013, Nature Reviews Clinical Oncology.

[15]  A. Maxmen.  Hard Facts , 2022, Consumer Electronics Test & Development.

[16]  Denis Evoy,et al.  CA 15-3: uses and limitation as a biomarker for breast cancer. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[17]  Martina Tinzl,et al.  DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer. , 2004, European urology.

[18]  V. Vasioukhin,et al.  The Origin and Mechanism of Circulating DNA , 2000, Annals of the New York Academy of Sciences.

[19]  C. Valeri,et al.  Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Larsen,et al.  Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer , 2013, Breast Cancer Research and Treatment.

[21]  H. Binder,et al.  Novel circulating microRNA signature as a potential non‐invasive multi‐marker test in ER‐positive early‐stage breast cancer: A case control study , 2014, Molecular oncology.

[22]  Xi Chen,et al.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Anatoly Dritschilo,et al.  Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer , 2014, Molecular oncology.

[24]  Daniel F. Hayes,et al.  Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer , 2013 .

[25]  Howard Y. Chang,et al.  Detection of Long Non-Coding RNA in Archival Tissue: Correlation with Polycomb Protein Expression in Primary and Metastatic Breast Carcinoma , 2012, PloS one.

[26]  M. Cantile,et al.  Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas , 2003, Oncogene.

[27]  Nathan C. Sheffield,et al.  The accessible chromatin landscape of the human genome , 2012, Nature.

[28]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[29]  G. Lemesle,et al.  Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure , 2014, Circulation research.

[30]  H. Reber,et al.  Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. , 2006, Clinical chemistry.

[31]  W. Koh,et al.  Noninvasive in vivo monitoring of tissue-specific global gene expression in humans , 2014, Proceedings of the National Academy of Sciences.

[32]  R. Catarino,et al.  Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. , 2008, DNA and cell biology.

[33]  A. V. Starikov,et al.  Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation , 2006, British Journal of Cancer.

[34]  N. Bertos,et al.  Breast cancer - one term, many entities? , 2011, The Journal of clinical investigation.

[35]  Mariano Provencio,et al.  Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  J. Hou,et al.  Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. , 2013, European journal of cancer.

[37]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[38]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  S. Srivastava,et al.  Prostate cancer: Diagnostic performance of the PCA3 urine test , 2011, Nature Reviews Urology.

[40]  Matthew T. Maurano,et al.  Widespread plasticity in CTCF occupancy linked to DNA methylation , 2012, Genome research.

[41]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[42]  Sota Asaga,et al.  Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. , 2011, Clinical chemistry.

[43]  G. Calin,et al.  Identification of circulating MicroRNA signatures for breast cancer detection , 2014 .

[44]  Karen Page,et al.  Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. , 2012, Genome research.

[45]  R. Spizzo,et al.  Long non-coding RNAs and cancer: a new frontier of translational research? , 2012, Oncogene.

[46]  G. Lemesle,et al.  The Circulating Long Non-Coding RNA LIPCAR Predicts Survival in Heart Failure Patients , 2014 .

[47]  George A Calin,et al.  A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients , 2014, Clinical Cancer Research.

[48]  M. Ranson,et al.  Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer , 2010, Breast Cancer Research and Treatment.

[49]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[50]  Hans-Peter Lenhof,et al.  A Different View on DNA Amplifications Indicates Frequent, Highly Complex, and Stable Amplicons on 12q13-21 in Glioma , 2008, Molecular Cancer Research.

[51]  Apiwat Mutirangura,et al.  Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma. , 2007, Clinica chimica acta; international journal of clinical chemistry.